Horien Biochemical Technology Co (ROCO:7814) Total Operating Expense: NT$31.41 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:7814 Horien Biochemical Technology Co Ltd ROCO:7814
21 GF Score
Price NT$37.80
! 5 Warning Signs
View Full Analysis

What is Horien Biochemical Technology Co Total Operating Expense?

Horien Biochemical Technology Co ROCO:7814 +2.02% 21 Total Operating Expense is NT$31.41 Mil as of Dec. 2025. GuruFocus rates ROCO:7814 with a GF Score™ of 21/100. The stock has 5 warning signs investors should review.

Horien Biochemical Technology Co's Total Operating Expense for the three months ended in Dec. 2025 was NT$15.94 Mil. Horien Biochemical Technology Co's Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 was NT$31.41 Mil.

Horien Biochemical Technology Co Total Operating Expense Related Terms

Horien Biochemical Technology Co Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Horien Biochemical Technology Co's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Horien Biochemical Technology Co Total Operating Expense Chart

Horien Biochemical Technology Co Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Total Operating Expense
37.68 40.93 57.28 66.71

Horien Biochemical Technology Co Quarterly Data
Dec22 Dec23 Jun24 Sep24 Dec24 Jun25 Sep25 Dec25
Total Operating Expense Get a 7-Day Free Trial 13.99 16.50 0.00 15.47 15.94
ROCO:7814
21GF Score
Horien Biochemical Technology Co Ltd ROCO:7814
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Horien Biochemical Technology Co Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$31.41 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of NT$31.41 Mil mean?
Horien Biochemical Technology Co (ROCO:7814) has a Total Operating Expense of NT$31.41 Mil as of Dec. 2025. Total operating expense is the primary recurring expense associated with central operations. View historical data on Horien Biochemical Technology Co and its competitors.
Is Horien Biochemical Technology Co's Total Operating Expense too high?
Horien Biochemical Technology Co's current Total Operating Expense is NT$31.41 Mil. Overall, Horien Biochemical Technology Co has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Horien Biochemical Technology Co's Total Operating Expense compare to VRTX and REGN?
Horien Biochemical Technology Co's Total Operating Expense of NT$31.41 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Biotechnology company?
A good Total Operating Expense depends on the Biotechnology industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Horien Biochemical Technology Co and its competitors. Horien Biochemical Technology Co's current Total Operating Expense is NT$31.41 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Horien Biochemical Technology Co stock overvalued right now?
Horien Biochemical Technology Co (ROCO:7814) has a current Total Operating Expense of NT$31.41 Mil. The current Total Operating Expense is NT$31.41 Mil. Horien Biochemical Technology Co's overall GF Score™ is 21/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Horien Biochemical Technology Co (ROCO:7814), the current Total Operating Expense is NT$31.41 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Horien Biochemical Technology Co Business Description

Address Gongyecyu 38th Road, 7F-5 & 6, NO. 210, Situn District, Siehe Village, Taichung, TWN, 40768
Horien Biochemical Technology Co Ltd is engaged in the research and development of cosmetic raw materials and medical devices and facilities. The products of the company include Gen-Nusis, skin repairment ingredients, PeptioMax, the latest cosmetic raw material, Lifkin, and other substitutes used in dentistry and general surgery.
21GF Score

Get the complete analysis for ROCO:7814

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$37.80
Price